← Back to Search

Spire Medical Health Tag for Healthy Subjects

N/A
Waitlist Available
Led By Arthur Cabrera, MD
Research Sponsored by Spire, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights

Summary

This usability validation testing protocol outlines the methods being used to demonstrate and gather evidence that the current design and user experience of the Spire Remote Patient Monitor are safe and effective for use by the people who are representative of the intended users under expected use conditions. This summative testing is the culmination of several preliminary analyses including a formative usability evaluation via Cognitive Expert Review Panel and is intended to assess the effectiveness of control measures put in place to reduce/eliminate use-related hazards or potential use errors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assess the participant's ability to perform essential tasks related to handling of device measured by Pass/Fail

Trial Design

1Treatment groups
Experimental Treatment
Group I: Spire Medical Health TagExperimental Treatment1 Intervention
Health Monitor Use
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spire Health Monitor
2019
N/A
~20

Find a Location

Who is running the clinical trial?

Spire, Inc.Lead Sponsor
6 Previous Clinical Trials
1,336 Total Patients Enrolled
Clinimark, LLCOTHER
22 Previous Clinical Trials
953 Total Patients Enrolled
Arthur Cabrera, MDPrincipal InvestigatorMedical Director for Clinimark LLC
10 Previous Clinical Trials
208 Total Patients Enrolled
~3 spots leftby Sep 2025